Boehringer Ingelheim RCV GmbH & Co KG
What Top Employers say about themselves
Boehringer Ingelheim Regional Center Vienna (RCV)
The Austrian subsidiary of the international group, founded in 1948 in a pharmacy in Vienna, was Boehringer Ingelheim’s first foreign company. From its modest beginnings, it has developed to become a modern high-technology company.
Today, the Boehringer Ingelheim Regional Center Vienna is responsible for the company’s business with prescription medications and veterinary medicines in Austria and more than thirty countries in Central and Eastern Europe and Central Asia, as well as Israel and Switzerland. In addition, all of the clinical research in the region is managed from Vienna. Vienna is the main center of cancer research as well as where the Group’s biopharmaceutical research, development and production takes place. Boehringer Ingelheim also engages in basic research at the Research Institute of Molecular Pathology (IMP) in Vienna. In 2018, the Regional Center Vienna showed an operating performance of EUR 1,385.5 million, total sales of EUR 897.5 million and employed 3,494 people throughout the region, thereof 1833 in Austria.
Number of employees:
Number of active countries: 146
Our comprehensive independent research revealed that Boehringer Ingelheim RCV GmbH & Co KG provides exceptional employee conditions, nurtures and develops talent throughout all levels of the organisation and has demonstrated its leadership status in the HR environment, always striving to optimise its employment practices and to develop its employees.
We help your organisation adapt to the rapidly changing HR environmentHow we certify